Summary In this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054 There's a bit too much talk about weightlifting though...

Summary In this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054 There's a bit too much talk about weightlifting though...

Summary In this Episode, hosts James &amp; Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054 There's a bit too much talk about weightlifting though...

Ep 76: KEYNOTE 054 7-year follow-up

From the UK to the USA - Melanoma Matters is on a mission!

Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). 

#MelanomaMatters video podcast

Medicine

Health & Fitness

From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast

Share Ep 76: KEYNOTE 054 7-year follow-up

Sign up to save your podcasts

Ep 76: KEYNOTE 054 7-year follow-up

Ep 76: KEYNOTE 054 7-year follow-up

More shows like Melanoma Matters

Pod Save America